3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
10
Squamous Cell Carcinoma of Head and Neck
3
Oropharyngeal Neoplasms
3
Neoplasm Metastasis
3
Uterine Cervical Neoplasms
2
Sarcoma
2
Prostatic Neoplasms
2
Pheochromocytoma
2
Paraganglioma
2
Ovarian Neoplasms
2
Multiple Myeloma
2
Mouth Neoplasms
2
Melanoma
2
Lung Neoplasms
2
Leukemia, Myeloid, Acute
2
Hodgkin Disease
2
Cholangiocarcinoma
2
Carcinoma, Hepatocellular
2
Anus Neoplasms
2
Uveal Melanoma
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Stage III Lung Non-Small Cell Cancer AJCC v7
1
Solid Tumor
1
Small Cell Lung Carcinoma
1
Rhabdoid Tumor
1
Rectal Neoplasms
1
Neuroendocrine Tumors
1
Neoplasms
1
Interventions
Oxaliplatin
14
Leucovorin
12
Fluorouracil
12
Cetuximab
10
Bevacizumab
9
pembrolizumab
7
Specimen Handling
7
Nivolumab
6
Magnetic Resonance Spectroscopy
6
Irinotecan
5
encorafenib
4
Pemetrexed
4
Gemcitabine
4
Cisplatin
4
Capecitabine
4
fludarabine
3
cemiplimab
3
Laparoscopy
3
Folfox protocol
3
Early Intervention, Educational
3
Cyclophosphamide
3
Carboplatin
3
Biopsy
3
trifluridine tipiracil drug combination
2
pertuzumab
2
durvalumab
2
dehydroftorafur
2
aldesleukin
2
X-Rays
2
Watchful Waiting
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Colonic Neoplasms
×
Fluorodeoxyglucose F18
×
90 days
×
Clear all
No trials found.